title: Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells.
abstract: Streptococcus agalactiae, or group B Streptococcus (GBS), is an important opportunistic pathogen that causes pneumonia, sepsis, and meningitis in neonates and severe diseases in immunocompromised adults. We have performed comparative genomics of prevalent GBS serotypes of Indian origin (i.e. Ia, III, V, and VII). Pilus-proteins were commonly found up-regulated, and their expression was studied by using antiserum for GBS80 (backbone protein of pilus island-I), GBS67 (ancillary protein of PI-2a), and SAN1518 (backbone protein of PI-2b) by whole cell and Western blot analysis. To check the role of pilus proteins in adherence and invasion, an inhibition assay was performed. Comparative immunoblotting experiments revealed that expression of pili proteins does not differ in geographically different selected serotypes, Ia and V, of India and the United States. In the case of A549 cells, we found that GBS VII invasion and adherence was inhibited by pilus protein-specific antiserum SAN1518 significantly (p < 0.001) by 88.5 and 91%, respectively. We found that mutant strains, deficient in the pilus proteins (Δgbs80 and Δsan1518) exhibit a significant decrease in adherence in the case of type Ia, III, and VII. In the case of type VII, we have found a 95% reduction in invasion when Δsan1518 was used with A549 cells. Because the pilus proteins were identified previously as vaccine candidates against GBS serotypes of developed countries, we also found their role in the attachment and invasion of GBS of Indian origin. Thus, the present work supports the idea of making a more effective pilus protein-based vaccine that can be used universally.
authors.affiliation: School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
authors.forename: Puja
authors.initials: P
authors.lastname: Sharma
authors.forename: Hem
authors.initials: H
authors.lastname: Lata
authors.forename: Deepak Kumar
authors.initials: DK
authors.lastname: Arya
authors.forename: Arun Kumar
authors.initials: AK
authors.lastname: Kashyap
authors.forename: Hemant
authors.initials: H
authors.lastname: Kumar
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Dua
authors.forename: Arif
authors.initials: A
authors.lastname: Ali
authors.forename: Atul Kumar
authors.initials: AK
authors.lastname: Johri
mesh_terms: D000328:Adult; D001422:Bacterial Adhesion; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D002584:Cervix Uteri / Q000378:metabolism* / Q000382:microbiology / Q000473:pathology; D004847:Epithelial Cells / Q000378:metabolism* / Q000382:microbiology / Q000473:pathology; D005260:Female; D010861:Fimbriae, Bacterial / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007194:India; D008168:Lung / Q000378:metabolism* / Q000382:microbiology / Q000473:pathology; D008297:Male; D013290:Streptococcal Infections / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control; D022541:Streptococcal Vaccines / Q000235:genetics / Q000627:therapeutic use; D013292:Streptococcus agalactiae / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D014481:United States
chemical_list: D001426:Bacterial Proteins; D022541:Streptococcal Vaccines